These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 19834903)
1. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction. Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903 [TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of tumor cells after induction of telomere dysfunction. Zimmermann S; Biniossek ML; Pantic M; Pfeifer D; Veelken H; Martens UM Proteomics; 2009 Feb; 9(3):521-34. PubMed ID: 19132685 [TBL] [Abstract][Full Text] [Related]
3. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
4. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. Wadhwa R; Takano S; Taira K; Kaul SC J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818 [TBL] [Abstract][Full Text] [Related]
5. S100A6 binds p53 and affects its activity. Słomnicki ŁP; Nawrot B; Leśniak W Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292 [TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death. Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603 [TBL] [Abstract][Full Text] [Related]
7. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188 [TBL] [Abstract][Full Text] [Related]
8. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy. Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53. Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373 [TBL] [Abstract][Full Text] [Related]
11. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Kang MK; Guo W; Park NH Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392 [TBL] [Abstract][Full Text] [Related]
12. Telomerase, senescence and ageing. Shawi M; Autexier C Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413 [TBL] [Abstract][Full Text] [Related]
13. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB. Króliczak W; Pietrzak M; Puzianowska-Kuznicka M Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402 [TBL] [Abstract][Full Text] [Related]
14. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line. Pantic M; Zimmermann S; Waller CF; Martens UM Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713 [TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532). El Daly H; Martens UM Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817 [TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic profiling of tumor cell response to telomere dysfunction using isotope-coded protein labeling (ICPL) reveals interaction network of candidate senescence markers. Biniossek ML; Lechel A; Rudolph KL; Martens UM; Zimmermann S J Proteomics; 2013 Oct; 91():515-35. PubMed ID: 23969227 [TBL] [Abstract][Full Text] [Related]
17. Replicative senescence in sheep fibroblasts is a p53 dependent process. Davis T; Skinner JW; Faragher RG; Jones CJ; Kipling D Exp Gerontol; 2005; 40(1-2):17-26. PubMed ID: 15664728 [TBL] [Abstract][Full Text] [Related]
18. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres. Goodwin EC; DiMaio D Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350 [TBL] [Abstract][Full Text] [Related]
20. [Effects of 3'-azido-deoxythymidine on telomerase activity and protein expression of hepatocarcinoma cell line SMMC-7721]. He M; Jiang YY; Zhu M; Wei X; Qin J; Zhang ZY; Li L Ai Zheng; 2006 May; 25(5):543-8. PubMed ID: 16687071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]